European Disease Progression Monitor: Edition 4

COVID-19 disease progression monitor

EU Disease-progression-review

Italy, Spain and France past COVID-19 peak

Germany and U.K. later peaks than EU

latest death rate in EU

EU5 past COVID-19 peak intensity

COVID-19 treatments and preventative therapies

disease progression monitor disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition III

Related Insights

Executive Insights

Life Sciences & Pharma

Opportunities for Rare Diseases to Drive Growth in Big Pharma

December 1, 2025

Contract/Pharma Services

Indonesia’s Clinical Trial Ecosystem: From Potential to Performance

November 25, 2025

Executive Insights

Life Sciences & Pharma

Indonesia’s Retail Pharmacy Landscape: Why Global Investors Should Take a Closer Look

October 16, 2025

Video / Webinar

Healthcare

Australia's Private Healthcare Sector: Strategic Outlook and Opportunities

October 6, 2025

Life Sciences & Pharma

On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (China)

July 22, 2025

Organization & Performance

Procurement Excellence as Competitive Advantage: Lowering Costs to Elevate Products

May 6, 2025